HIMS DOWN: Hims revenue surges, losses widen | Ezbrisk
By: Ezbrisk
Published:
Anomaly score: -1.4561570117125704
Confidence: 0.75
Market summary
Hims revenue surges, losses widen
Ezbrisk assessment
Hims & Hers Health reported Q2 2026 revenue of roughly $753 million, up 38% year-over-year and beating expectations, but swung to a net loss of $86 million versus prior-year profit, with Adjusted EBITDA falling to $60 million from $82 million, while the company raised full-year revenue guidance to $3.1 billion-$3.3 billion and updated Adjusted EBITDA guidance to $275 million-$325 million, and the stock moved moderately lower in after-hours trading.
Sources: https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/hims-20260810.htm, https://www.sec.gov/Archives/edgar/data/1773751/000177375126000163/hims-20260630.htm, https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/hims-20260630x8xkearningsr.htm
Verdict ID: 88b8268b-a694-4913-896c-f2acc724855e